Gene Therapy For Rare Disease Market Scope And Analysis

  • Report Code : TIPRE00003413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti della terapia genica per le malattie rare entro il 2025-2031

Buy Now

Gene Therapy For Rare Disease Market Report Gene Therapy For Rare Disease Market Size and Share Gene Therapy For Rare Disease Market Scope and Analysis

Gene Therapy For Rare Disease Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Applicazione terapeutica
  • oncologia
  • disturbi neurologici
  • disturbi oftalmici
  • disturbi ematologici
  • disturbi da immunodeficienza
  • disturbi metabolici
  • altri
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • BioMarin
  • Orchard Therapeutics plc.
  • Spark Therapeutics, Inc.
  • PTC Therapeutics
  • bluebird bio, Inc.
  • Kite Pharma
  • uniQure N.V.
  • Juno Therapeutics Inc. (Celgene Corporation)
  • Novartis AG